Hansa Biopharma Hosts Virtual Event with Transplant Surgeons
Hansa Biopharma AB announced a virtual event featuring Professor Robert Montgomery and Professor Matthew Cooper to discuss the medical journey of highly sensitized patients awaiting a kidney transplant.
The event will take place on November 12, 2025, at 9:00 AM EST / 15:00 PM CET, and will include insights on clinical practice and imlifidase Phase 3 results.
The virtual event will provide deeper insights into the medical journey of highly sensitized patients awaiting a kidney transplant and share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: Hansa Biopharma hosts virtual event on kidney transplant.